| Human gastric cancer modelling using organoids T Seidlitz, SR Merker, A Rothe, F Zakrzewski, C von Neubeck, ... Gut 68 (2), 207-217, 2019 | 262 | 2019 |
| HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a … F Lohaus, A Linge, I Tinhofer, V Budach, E Gkika, M Stuschke, ... Radiotherapy and oncology 113 (3), 317-323, 2014 | 162 | 2014 |
| HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary … A Linge, F Lohaus, S Löck, A Nowak, V Gudziol, C Valentini, ... Radiotherapy and Oncology 121 (3), 364-373, 2016 | 150 | 2016 |
| Relative biological effectiveness in proton beam therapy–Current knowledge and future challenges A Lühr, C von Neubeck, M Krause, EGC Troost Clinical and translational radiation oncology 9, 35-41, 2018 | 145 | 2018 |
| Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV (−) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG A Linge, S Löck, V Gudziol, A Nowak, F Lohaus, C von Neubeck, M Jütz, ... Clinical cancer research 22 (11), 2639-2649, 2016 | 130 | 2016 |
| “Radiobiology of Proton Therapy”: Results of an international expert workshop A Lühr, C von Neubeck, J Pawelke, A Seidlitz, C Peitzsch, SM Bentzen, ... Radiotherapy and Oncology 128 (1), 56-67, 2018 | 107 | 2018 |
| Toward A variable RBE for proton beam therapy H Willers, A Allen, D Grosshans, SJ McMahon, C von Neubeck, C Wiese, ... Radiotherapy and Oncology 128 (1), 68-75, 2018 | 93 | 2018 |
| DNA damage response assessments in human tumor samples provide functional biomarkers of radiosensitivity H Willers, L Gheorghiu, Q Liu, JA Efstathiou, LJ Wirth, M Krause, ... Seminars in radiation oncology 25 (4), 237-250, 2015 | 87 | 2015 |
| Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs C Von Neubeck, A Seidlitz, HH Kitzler, B Beuthien-Baumann, M Krause The British journal of radiology 88 (1053), 20150354, 2015 | 78 | 2015 |
| Influence of acute hypoxia and radiation quality on cell survival W Tinganelli, NY Ma, C Von Neubeck, A Maier, C Schicker, ... Journal of radiation research 54 (suppl_1), i23-i30, 2013 | 70 | 2013 |
| Development and validation of a gene signature for patients with head and neck carcinomas treated by postoperative radio (chemo) therapy S Schmidt, A Linge, A Zwanenburg, S Leger, F Lohaus, C Krenn, ... Clinical Cancer Research 24 (6), 1364-1374, 2018 | 54 | 2018 |
| γH2AX assay in ex vivo irradiated tumour specimens: A novel method to determine tumour radiation sensitivity in patient-derived material A Menegakis, C von Neubeck, A Yaromina, H Thames, S Hering, ... Radiotherapy and Oncology 116 (3), 473-479, 2015 | 53 | 2015 |
| Residual γH2AX foci predict local tumour control after radiotherapy U Koch, K Höhne, C von Neubeck, HD Thames, A Yaromina, ... Radiotherapy and Oncology 108 (3), 434-439, 2013 | 49 | 2013 |
| The why and how of amino acid analytics in cancer diagnostics and therapy F Manig, K Kuhne, C von Neubeck, U Schwarzenbolz, Z Yu, BM Kessler, ... Journal of biotechnology 242, 30-54, 2017 | 47 | 2017 |
| Irradiation verification device for radiotherapy installations, and method for handling thereof CH Von Neubeck, W Kraft-Weyrather, CS Hartel US Patent 8,002,466, 2011 | 41 | 2011 |
| Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate KM Waters, DL Stenoien, MB Sowa, C von Neubeck, WB Chrisler, R Tan, ... Radiation research 179 (1), 53-61, 2013 | 36 | 2013 |
| Research facility for radiobiological studies at the university proton therapy dresden E Beyreuther, M Baumann, W Enghardt, S Helmbrecht, L Karsch, ... International Journal of Particle Therapy 5 (1), 172-182, 2018 | 35 | 2018 |
| Modeling in vivo relative biological effectiveness in particle therapy for clinically relevant endpoints A Lühr, C von Neubeck, S Helmbrecht, M Baumann, W Enghardt, ... Acta Oncologica 56 (11), 1392-1398, 2017 | 29 | 2017 |
| Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC A Linge, U Schötz, S Löck, F Lohaus, C von Neubeck, V Gudziol, ... Radiotherapy and Oncology 127 (1), 27-35, 2018 | 27 | 2018 |
| Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy A Linge, S Schmidt, F Lohaus, C Krenn, A Bandurska-Luque, I Platzek, ... Clinical and translational radiation oncology 16, 40-47, 2019 | 26 | 2019 |
